In the spleen, 3 days post arthritis induction, the mean percentage of CD4+ cells did not vary between MSC, CM-MSC and SFM control treatments (9.83 ± 1.54%, 11.36 ± 1.60%, 10.30 ± 1.60% respectively). This evidence concerns the gene CD4 and arthritic joint disease.